dismiss

Clean Sweep Live Auction on Wed. November 14th. over 3,100 items - Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Missouri reactor becomes sole U.S. domestic source of I-131 A vital radioisotope in the fight against thyroid cancer and hyperthyroidism

Cardinal Health to distribute IRE ELiT's 68-Ga generators Aiming to alleviate access shortages with Galli Eo generators

Zionexa partners with Columbia PET Center on development of EstroTep Identifies estrogen receptor status to diagnose metastatic breast cancer

Canada to build medical isotope research and development center Will act as a regional source for isotopes, including Tc-99m

RefleXion demonstrates BgRT PET system at ASTRO Treat all stages of cancer, including metastatic

GE to provide training to at least 140 Kenyan radiographers Partnering with Society of Radiography in Kenya

NorthStar, Shine in line for federal funding Bringing $20 million in additional funding to domestic moly-99 in the US

Adel Abdullah and Aaron Hargrave Positron appoints president and vice president

Theranostics – Nuclear medicine´s fountain of youth Combining therapeutics with diagnostics, opportunities and challenges

New House bill calls for change in CMS definition of radiopharmaceuticals Reimburse separately instead of as bundled payment

The shutdown of two reactors has
caused an anticipated shortage of Mo-99
for the first half of November, according
to an SNMMI warning

SNMMI warns providers to prep for expected shortage of Mo-99

by John R. Fischer , Staff Reporter
The Society of Nuclear Medicine and Molecular Imaging is warning providers to prep for an expected shortage of Mo-99 during the first half of November.

Its announcement follows the commencement this week of a planned 11-day shutdown of the Open Pool Australian Lightwater (OPAL) reactor for maintenance, as well as the ongoing suspension of activity at the NTP Radioisotopes facility in South Africa, which ceased production last November following the discovery of a suspected hydrogen leak.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!



“With significant shortages anticipated, it is essential that users contact their generator/nuclear pharmacy providers for advice about their local situation,” said SNMMI in a statement. “The Association of Imaging Producers & Equipment Suppliers (AIPES) Emergency Response Team is closely following the situation. The group issued an update on October 30, and SNMMI will post updates as they become available.”

The U.S. consumes approximately 50 percent of the world's supply of Mo-99 and relies on a significant amount of Iodine-131 (I-131) for nuclear medicine procedures, which benefit More than 20 million Americans annually. More than half of these patients are in need of Technetium-99m, the daughter isotope of Mo-99, and many also require I-131 for diagnostic and therapeutic procedures, making them particularly vulnerable to shortages of both due to the NTP and now, OPAL, suspensions.

The shutdown of the OPAL reactor is the second this year in the land down under to affect access to Mo-99 worldwide, the first being the suspension of Tc-99m generator production back in July due to a mechanical failure in a transfer conveyor. Production resumed a month later.

The lack of generators, where bulk Mo-99 exports are stored and decay into Tc-99m during transport to healthcare facilities, disrupted access to the radioisotope for nuclear medicine providers throughout Australia, the U.S. and other countries, subsequently delaying necessary exams for patients.

The shutdown over the last year of the NTP facility in Pelindaba, South Africa has also presented challenges, with the plant one of four Mo-99 processing facilities worldwide that extracts Mo-99 from uranium targets and purifies it for shipment to Tc-99 generator manufacturers. It currently provides 20 percent of global demand for Mo-99.

Despite a brief and temporary return to service in February, production issues once again placed and have kept the reactor offline.
  Pages: 1 - 2 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED